GridAI Technologies GRDX
NASDAQ GRDX
$2.97 -0.05 (-1.66%)
At close: Sep 10, 2026 · 4:00 PM EDT

GridAI Technologies (GRDX) Operating Leases (2020 - 2024)

GridAI Technologies' (GRDX) quarterly Operating Leases came in at $59024.0 in Q4 2024, down 59.83% on a YoY basis from $146949.0 in Q1 2024, and down 26.42% quarter-over-quarter from $80213.0 in Q3 2024.

Analysis

GridAI Technologies (GRDX) Operating Leases (2020 - 2024) Analysis & Trends

GridAI Technologies (GRDX) has reported Operating Leases for 5 consecutive years, with $59024.0 the latest figure, recorded in Q4 2024.

  • For the quarter ending Q4 2024, Operating Leases fell 59.83% year-over-year to $59024.0; the trailing twelve-month figure through Dec 2024 stood at $59024.0 (down 59.83% YoY), and the FY2024 full-year result was $59024.0, down 59.83% from the prior year.
  • Operating Leases slipped to $59024.0 in Q4 2024 per GRDX's latest filing, from $80213.0 in the prior quarter.
  • Across five years, Operating Leases topped out at $311138.0 in Q4 2021 and bottomed at $6566.0 in Q1 2021.
  • Historically, Operating Leases has averaged $163382.4 across 5 years, with a median of $165970.0 in 2023.
  • The sharpest annual moves came in 2021 and 2024: Operating Leases surged 1527.04% in 2021, then sank 59.83% in 2024.
  • Over 5 years, Operating Leases stood at $19123.0 in 2020, then surged by 1527.04% to $311138.0 in 2021, then slumped by 31.2% to $214060.0 in 2022, then slumped by 31.35% to $146949.0 in 2023, then sank by 59.83% to $59024.0 in 2024.
  • According to Business Quant data, Operating Leases over the past three periods registered $59024.0, $80213.0, and $101035.0 for Q4 2024, Q3 2024, and Q2 2024 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn
10 GridAI Technologies 19.07 Mn 19.07 Mn -36,514.00
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 59,024.00
Sep 30, 2024 80,213.00
Jun 30, 2024 101,035.00
Mar 31, 2024 127,592.00
Dec 31, 2023 146,949.00
Sep 30, 2023 165,970.00
Jun 30, 2023 184,662.00
Mar 31, 2023 196,524.00
Dec 31, 2022 214,060.00
Sep 30, 2022 231,292.00
Jun 30, 2022 310,899.00
Dec 31, 2021 311,138.00
Sep 30, 2021 295,689.00
Mar 31, 2021 6,566.00
Dec 31, 2020 19,123.00